Top Healthcare Stocks
Healthcare stocks were moderately lower with the NYSE Healthcare
Sector Index sinking about 0.4% and shares of healthcare companies
in the S&P 500 down around 0.3% as a group.
In company news, Actavis plc (
) was hanging on to a 2% gain late in Monday's session after
analysts at Morgan Stanley today resumed coverage of the drugmaker
with an Overweight rating and a $300 a share price target, up $70
over its prior outlook.
ACT shares were up 2% at $221.31 each this afternoon, earlier
advancing to a session high of $233.18 a share. The stock has a
52-week range of $118.92 to $230.77 a share, rising slightly more
than 82% over the past 12 months.
In other sector news,
(+) NSPH, Inks deal with Parallon to supply its HealthTrust
hospital chain with Verigene diagnostic tests to identify and treat
patient infections. Financial terms were not disclosed but NSPH
said the deal includes all 1,400 Healthtrust facilities.
(-) BLRX, Licenses BL-1110 drug candidate for treatment of
neuropathic pain after the experimental drug was shown in
pre-clinical studies to enhance analgesic effects of morphine while
also reducing negative side effects.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.